Abstract:The association between methylenetetrahy- drofolate reductase (MTHFR) gene polymorphisms and breast cancer risk has been widely reported, but results were inconsistent and underpowered. To clarify the effects of MTHFR polymorphisms on the risk of breast cancer, an updated meta-analysis of all available studies relating C677T and/or A1298C polymorphisms of MTHFR gene to the risk of breast cancer was conducted. Eligible articles were identified by search of databases including MED- LINE, PubMed, Web of Science, EMBASE and Chinese Biomedical Literature database (CBM) for the period up to January 2010. Finally, a total of 41 studies with 16,480 cases and 22,388 controls were included, all for C677T polymorphism and 20 with 12,170 cases and 15,865 con- trols for A1298C polymorphism. The pooled ORs were performed for the allele contrasts, additive genetic model, dominant genetic model, and recessive genetic model, respectively. Subgroup analyses were also performed by ethnicity and menopausal status. With respect to C677T polymorphism, significantly elevated breast cancer risk was found in overall analysis (T vs. C: OR = 1.041, 95% CI = 1.009-1.073; TT vs. CC: OR = 1.132, 95% CI = 1.019-1.259; TT vs. CC ? CT: OR = 1.119, 95% CI = 1.014-1.236); in the subgroup analysis by ethnicity, significantly increased risk was found in East Asian pop- ulation (T vs. C: OR = 1.121, 95% CI = 1.016-1.237; TT vs. CC: OR = 1.331, 95% CI = 1.073-1.650; TT vs. CC ? CT: OR = 1.265, 95% CI = 1.058-1.513) but not in Caucasian population; in the subgroup analysis by menopausal status, no statistically significant association was found. With respect to A1298C polymorphism, no significant association with breast cancer risk was dem- onstrated in overall, ethnicity- and menopausal status- based population. It can be concluded that potentially functional MTHFR C677T polymorphism may play a low penetrance role in the development of breast cancer.

A Case-Control Study on the Polymorphisms of Methylenetetrahydrofolate Reductases, Drinking Interaction and Susceptibility in Colorectal Cancer

Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.

Association Between the MTHFR A1298C Polymorphism and Risk of Cancer: Evidence from 265 Case–control Studies

FOLIC ACID,METHIONINE,AND POLYMORPHISMS OF METHYLENETETRAHYDROFOLATE REDUCTASES AND SUSCEPTIBILITY OF COLORECTAL CANCER

[Association Between Genetic Polymorphisms in Folate Metabolic Enzyme Genes and Colorectal Cancer: a Nested Case-Control Study].

Meta-analysis on the Relationship Between MTHFR Gene Polymorphisms and Colorectal Cancer

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

Relationship between MTHFR C677T Polymorphisms and Susceptibility of Digestive System Cancer and Coronary Heart Disease

Associations Between Genetic Polymorphisms of Glutathione S-transferase M1 and T1,smoking and Susceptibility to Colorectal Cancer:A Case-Control Study

[Association Between Genetic Polymorphisms of Metabolic Enzymes and Susceptibility of Colorectal Cancer].

[Application of Multifactor Dimensionality Reduction on the Interactions Between Gene-Gene, Gene-Environment and the Risk Sporadic Colorectal Cancer in Chinese Population].

Association of MTHFR C677T Polymorphism and Type 2 Diabetes Mellitus (T2DM) Susceptibility

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

Relationship Between Polymorphisms of Thymidylate Synthase and Methylenetetrahydrofolate Reductase and Susceptibility in Liaoning Benxi Colorectal Cancer Patients

The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population.

5,10-Methylenetetrahydrofolate reductase ( MTHFR ), methionine synthase ( MTRR ), and methionine synthase reductase ( MTR ) gene polymorphisms and adult meningioma risk

Relationship between metabolic enzyme polymorphism and colorectal cancer.

Methylenetetrahydrofolate Reductase Polymorphisms and Breast Cancer Risk: a Meta-Analysis from 41 Studies with 16,480 Cases and 22,388 Controls

Exploration on the relationship between MTHFR(5,10-methylenetetrahydrofolate reductase) gene polymorphisms and the risk of primary liver cancer

[Association Between Genetic Variations in Methylenetetrahydrofolate Reductase and Risk of Colorectal Cancer in a Chinese Population].

The combined effect of MTHFR C677T and A1298C polymorphisms on the risk of digestive system cancer among a hypertensive population